252 related articles for article (PubMed ID: 32346435)
21. Actein Antagonizes Oral Squamous Cell Carcinoma Proliferation through Activating FoxO1.
Zhao C; Zhang Z; Dai X; Wang J; Liu H; Ma H
Pharmacology; 2021; 106(9-10):551-563. PubMed ID: 34175854
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of lncRNA TUG1 protects lens epithelial cells from oxidative stress-induced injury by regulating miR-196a-5p expression in age-related cataracts.
Shen Q; Zhou T
Exp Ther Med; 2021 Nov; 22(5):1286. PubMed ID: 34630641
[TBL] [Abstract][Full Text] [Related]
23. miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.
Wang XC; Ma Y; Meng PS; Han JL; Yu HY; Bi LJ
Oral Oncol; 2015 Jul; 51(7):674-82. PubMed ID: 25962939
[TBL] [Abstract][Full Text] [Related]
24. The role of HOXB9 and miR-196a in head and neck squamous cell carcinoma.
Darda L; Hakami F; Morgan R; Murdoch C; Lambert DW; Hunter KD
PLoS One; 2015; 10(4):e0122285. PubMed ID: 25860510
[TBL] [Abstract][Full Text] [Related]
25. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
Li N; Nan CC; Zhong XY; Weng JQ; Fan HD; Sun HP; Tang S; Shi L; Huang SX
Cell Physiol Biochem; 2018; 49(4):1329-1341. PubMed ID: 30205384
[TBL] [Abstract][Full Text] [Related]
26. LncRNA GAS5 suppresses the tumorigenesis of cervical cancer by downregulating miR-196a and miR-205.
Yang W; Hong L; Xu X; Wang Q; Huang J; Jiang L
Tumour Biol; 2017 Jul; 39(7):1010428317711315. PubMed ID: 28671039
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-363-3p inhibits tumor cell proliferation and invasion in oral squamous cell carcinoma cell lines by targeting SSFA2.
Zhu L; Zhang L; Tang Y; Zhang F; Wan C; Xu L; Guo P
Exp Ther Med; 2021 Jun; 21(6):549. PubMed ID: 33850521
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1.
Liu DZ; Chang B; Li XD; Zhang QH; Zou YH
Clin Transl Oncol; 2017 Sep; 19(9):1133-1140. PubMed ID: 28397066
[TBL] [Abstract][Full Text] [Related]
29. LINC01315 Impairs microRNA-211-Dependent DLG3 Downregulation to Inhibit the Development of Oral Squamous Cell Carcinoma.
Chen FB; Wu P; Zhou R; Yang QX; Zhang X; Wang RR; Qi SC; Yang X
Front Oncol; 2020; 10():556084. PubMed ID: 33117688
[TBL] [Abstract][Full Text] [Related]
30. miR-222 regulates the cell biological behavior of oral squamous cell carcinoma by targeting PUMA.
Jiang F; Zhao W; Zhou L; Zhang L; Liu Z; Yu D
Oncol Rep; 2014 Mar; 31(3):1255-62. PubMed ID: 24452416
[TBL] [Abstract][Full Text] [Related]
31. MiR-132 plays an oncogenic role in laryngeal squamous cell carcinoma by targeting FOXO1 and activating the PI3K/AKT pathway.
Lian R; Lu B; Jiao L; Li S; Wang H; Miao W; Yu W
Eur J Pharmacol; 2016 Dec; 792():1-6. PubMed ID: 27751825
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-375 Inhibits Growth and Enhances Radiosensitivity in Oral Squamous Cell Carcinoma by Targeting Insulin Like Growth Factor 1 Receptor.
Zhang B; Li Y; Hou D; Shi Q; Yang S; Li Q
Cell Physiol Biochem; 2017; 42(5):2105-2117. PubMed ID: 28810236
[TBL] [Abstract][Full Text] [Related]
33. miR-370 inhibits the oxidative stress and apoptosis of cardiac myocytes induced by hydrogen peroxide by targeting FOXO1.
Qiu Z; Wang L; Mao H; Xu F; Sun B; Lian X; Wang J; Kong F; Wang L; Chen Y
Exp Ther Med; 2019 Oct; 18(4):3025-3031. PubMed ID: 31555385
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-552 Accelerates the Progression of Gastric Cancer by Targeting FOXO1 and Regulating PI3K/AKT Pathway.
Zhao Y; Zhang J; Yang W; Yang Z; Zhou K
J Oncol; 2021; 2021():9966744. PubMed ID: 34035814
[TBL] [Abstract][Full Text] [Related]
35. MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1.
Zhang LY; Chen Y; Jia J; Zhu X; He Y; Wu LM
Cancer Biomark; 2019; 24(1):31-42. PubMed ID: 30614794
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6.
Wang X; Chang K; Gao J; Wei J; Xu G; Xiao L; Song G
Int J Biochem Cell Biol; 2020 Feb; 119():105663. PubMed ID: 31812760
[TBL] [Abstract][Full Text] [Related]
37. MiR-181d functions as a potential tumor suppressor in oral squamous cell carcinoma by targeting K-ras.
Shi Y; Li Y; Wu W; Xu B; Ju J
Int J Clin Exp Pathol; 2017; 10(7):7847-7855. PubMed ID: 31966632
[TBL] [Abstract][Full Text] [Related]
38. Atrasentan alleviates high glucose-induced podocyte injury by the microRNA-21/forkhead box O1 axis.
Wang J; Shen L; Hong H; Li J; Wang H; Li X
Eur J Pharmacol; 2019 Jun; 852():142-150. PubMed ID: 30876973
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.
Xu H; Zhu J; Hu C; Song H; Li Y
J Physiol Biochem; 2016 Dec; 72(4):721-732. PubMed ID: 27534652
[TBL] [Abstract][Full Text] [Related]
40. MiRNA-128 and MiRNA-142 Regulate Tumorigenesis and EMT in Oral Squamous Cell Carcinoma Through HOXA10.
Yao Y; Xu Q; Yan L; Jiao Y; Su Q; Li X; Liu C; Zhao F
Cancer Manag Res; 2020; 12():9987-9997. PubMed ID: 33116855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
